Searchable abstracts of presentations at key conferences in endocrinology

ea0049oc12.5 | Pituitary Clinical | ECE2017

Effects of pegvisomant and somatostatin receptor ligands on risk of vertebral fractures in patients with Acromegaly

Chiloiro Sabrina , Mazziotti Gherardo , Giampietro Antonella , Formenti Anna Maria , Bianchi Antonio , Mormando Marilda , Pontecorvi Alfredo , Giustina Andrea , De Marinis Laura

Acromegalic osteopathy is an emerging complication of chronic GH excess characterized by increase in bone turnover, deterioration in bone microarchitecture and high risk of vertebral fractures (VFs). Medical therapies may exert direct effects on peripheral targets leading to improvement of clinical outcomes regardless of biochemical control of acromegaly. In this longitudinal study, we compared the effects pegvisomant (PegV) and somatostatin receptor ligands (SRLs) on VF risk ...

ea0049gp228 | Thyroid Cancer | ECE2017

Differentiated thyroid cancer – comparison between patients with and without remission

Amado Ana , Gouveia Patricia , Pereira Teresa Alves , Castro Rosa , da Costa Antonio Moreira , Carvalho Andre , Freitas Claudia , Borges Fatima

Introduction: Differentiated thyroid cancer (DTC) is one of the most frequent forms of malignancy. Because of its favourable outcome and low mortality rates, identifying prognostic factors has been a challenge. Several risk stratification systems have been developed. Most of them include demographic and tumour specific features, as well as extrathyroidal extension. Our objective was to compare clinical characteristics between DTC patients with and without remission.<p clas...

ea0049ep389 | Clinical case reports - Thyroid/Others | ECE2017

Improved xanthomas after leptin replacement short therapy in congenital lipodystrophy patient

Oliveira-Filho Antonio F , Dantas Irla A , Velloso Renata N , de Oliveira Sofia N P , Candido Diego F F , Nunes Adriana

Berardinelli-Seip syndrome is an autosomal recessive disorder characterized by generalized lipoatrophy, extreme insulin resistance with dyslipidaemia in childhood and development of diabetes and hepatic steatosis in adolescence. The metabolic derangements can be severe and lead to substantial comorbidities, including acute pancreatitis, hepatic cirrhosis, and premature cardiovascular disease. Other manifestations can include polycystic ovarian syndrome, acanthosis nigricans, a...

ea0049ep991 | Pituitary - Clinical | ECE2017

Biochemical normalization in acromegaly after 79 months’ treatment with Pasireotide: case report

Bima Chiara , Chiloiro Sabrina , Iacovazzo Donato , Tartaglione Tommaso , Bracaccia Maria Elena , Giampietro Antonella , Bianchi Antonio , De Marinis Laura

Pasireotide, a multireceptor-targeted somatostatin analogue, was approved for the treatment of acromegaly, after being studied in two large, randomised, multi-center clinical trials. We reported the history of a 76 years old man affected by acromegaly, treated with Pasireotide long acting release (LAR) as first line therapy. Acromegaly was diagnosed in 2009, as the result of endocrinological investigation suggested by altered facial appearance and macroglossia. Hormonal assays...

ea0049ep1443 | Thyroid (non-cancer) | ECE2017

The sensitivity and positive predictive value (PPV) of 131I-post-therapy whole body scan is higher than serum Tg values in detecting metastases in early stage of differentiated thyroid cancer patients

Campenni Alfredo , Pignata Salvatore Antonio , Siracusa Massimiliano , Vicchio Teresa Manuela , Trimarchi Francesco , Ruggeri Rosaria Maddalena , Baldari Sergio

The work-up of Differentiated Thyroid Cancer (DTC) patients includes thyroid surgery, thyroid remnant ablation (TRA) with 131-radioiodine and long life follow-up. 131I-post therapy whole body scan (pT-WBS) and thyroglobulin (Tg) are used in identifying metastatic patients. Some authors suggested to use post-surgical Tg (ps-Tg) values in deciding for or against TRA. The aim of our study was to verify the sensitivity and PPV of 131I-pT-WBS compared to serum Tg levels in detectin...

ea0041oc11.3 | Bone &amp; Calcium Homeostasis | ECE2016

Ultra-trail marathon induces bone response in association with acute and established metabolic changes

Lombardi Giovanni , Sansoni Veronica , Perego Silvia , Vernillo Gianluca , Schena Federico , Merati Giampiero , Baruti Andrea , La Torre Antonio , Banfi Giuseppe

Introduction: Bone and energy metabolisms are deeply related determining a two-way street aimed in regulating the energy utilization [1]. Mountain ultra-marathons are peculiar aerobic performances hardly proving whole body homeostasis [2]. In this study we aimed at investigating and characterizing the metabolic profile (hormones involved in energy metabolism), the metabolic inflammation profile (adipokines), the bone metabolism (bone turnover markers), and their integration (m...

ea0041gp31 | Bone &amp; Calcium Homeostasis | ECE2016

Bone-specific circulating miRNA profile changes over an 8-week repeated sprint training protocol

Lombardi Giovanni , Sansoni Veronica , Perego Silvia , Vernillo Gianluca , Bonzanni Mattia , Merati Giampiero , Barbuti Andrea , La Torre Antonio , Banfi Giuseppe

Introduction: Although underlying mechanisms are largely unknown, bone metabolism is regulated by specific microRNAs and changes in their expression are associated with metabolic bone disorders. Exercise is a determinant of bone metabolism; however, different training protocols differently affect bone. Little is known about the effects of exercise on bone-specific miRNA expression.We studied the effect of a 8-week high-intensity training protocol on circ...

ea0041ep558 | Diabetes therapy | ECE2016

Dapagliflozin clinical experience and safety on patients with type 2 diabetes and obesity

del Mar Roca-Rodriguez Maria , Picon-Cesar Maria Jose , Omiste-Romero Antonio Jesus , Garcia-Perez Jorge , Aguilar-Diosdado Manuel

Introduction: New treatments of diabetes, such as dapagliflozin, improve global metabolic status beyond glycemic control.Aim: To evaluate tolerance to dapagliflozin and its effects on metabolic control in type 2 diabetes and obese patients attended in endocrinology offices.Material and method: A prospective study of patients with type 2 diabetes and obesity. In an intra-subject analysis, clinical and analytical data were evaluated ...

ea0037oc4.3 | Diabetes | ECE2015

Chronic, long-term administration of Vardenafil improves endothelial function and corrects hypogonadism in patients with type 2 diabetes mellitus. A longitudinal, prospective, randomized, placebo-controlled, double blind, clinical trial

Santi Daniele , Guidi Alessandro , Granata Antonio , Pignatti Elisa , Bozic Roberto , Zaza Stefano , Roli Laura , Trenti Tommaso , Carani Cesare , Simoni Manuela

Background: Endothelial dysfunction leads to cardiovascular complications in type 2 diabetes mellitus (T2DM), through a reduction of nitric oxide (NO)-mediated relaxation. Phosphodiesterase-5 inhibitors (PDE5i) have hemodynamic effects, improving NO levels.Aim: To investigate if long term, chronic treatment with the PDE5i Vardenafil improves systemic endothelial function in men with T2DM.Methods: A longitudinal, prospective, invest...

ea0037gp.18.08 | Pituitary–Basic and IGF-1 | ECE2015

Role of miR-375 in oncogenesis of pituitary adenomas

Sanchez-Tejada Laura , Sanchez-Ortiga Ruth , Riesgo Pedro , Abarca Javier , Fajardo Carmen , Monjas Irene , Camara Rosa , Lamas Cristina , Pico Antonio

Purpose: MicroRNAs (miRNAs) are a fundamental component of gene regulation mechanisms. Presently, altered miRNA patterns of expression have been documented in different human cancers, and they may explain the distinct behavior of pituitary adenomas (PA) and the differences between subtypes. miR-375 can target among other genes to IGF1 receptor (IGF1R) and participes in reprogramming cancer cell metabolism. The aim of this study was to assess the miR-375 role on pathogenesis of...